Apple Tree Partners leads $25 mln Series C round in Tendyne Holdings

Apple Tree Partners has led a $25 million Series C funding round in Tendyne Holdings, Inc., a privately held clinical stage medical device company developing technologies for transcatheter mitral valve replacement. Other participants in the funding round include Boulle Group members and other existing investors. David McIntyre, a partner at Apple Tree Partners, will join Tendyne's board of directors.

North AmericaUSBriefs